Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001801385-24-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-01 | 2024-02-28 | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $31.77 | +10.0K | 17.9K | +126% | +$317.8K |
| D | 2024-03-01 | 2024-02-28 | KRYS | ROMANO KATHRYN | CAO | F - Tax | $163.08 | -2,314 | 15.6K | -13% | -$377.4K |
| DM | 2024-03-01 | 2024-02-28 | KRYS | ROMANO KATHRYN | CAO | S - Sale+OE | $165.88 | -5,000 | 12.9K | -28% | -$829.4K |
| DM | 2024-03-01 | 2024-02-28 | KRYS | ROMANO KATHRYN | CAO | M - OptEx | $0.00 | -10.0K | 5,000 | -67% | $0 |
| D | 2024-03-01 | 2024-02-29 | KRYS | ROMANO KATHRYN | CAO | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 648 | $63.55 | 13,584 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 2,314 | $163.08 | 15,622 | D | — | — | (F10) Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 5,000 PSUs on February 28, 2024. (F11) The closing price on February 28, 2024 of the Company's common stock on NASDAQ. |
| 3 | Common | Common Stock | 2024-02-28 | M | A | 900 | $63.55 | 13,836 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-28 | S | D | 900 | $163.68 | 12,936 | D | — | — | (F3) The transaction was executed in multiple trades ranging from $163.190 to $164.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2024-02-28 | M | A | 1,429 | $63.55 | 14,365 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-28 | S | D | 1,429 | $164.81 | 12,936 | D | — | — | (F4) The transaction was executed in multiple trades ranging from $164.300 to $165.220. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 7 | Common | Common Stock | 2024-02-28 | M | A | 300 | $63.55 | 13,236 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-28 | S | D | 300 | $166.06 | 12,936 | D | — | — | (F5) The transaction was executed in multiple trades ranging from $165.980 to $166.110. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 9 | Common | Common Stock | 2024-02-28 | M | A | 300 | $63.55 | 13,236 | D | — | — | |
| 10 | Common | Common Stock | 2024-02-28 | S | D | 300 | $167.85 | 12,936 | D | — | — | (F6) The transaction was executed in multiple trades ranging from$167.540 to $168.010. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 11 | Common | Common Stock | 2024-02-28 | M | A | 1,216 | $63.55 | 14,152 | D | — | — | |
| 12 | Common | Common Stock | 2024-02-28 | S | D | 1,216 | $169.09 | 12,936 | D | — | — | (F7) The transaction was executed in multiple trades ranging from $168.680 to $169.610. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 13 | Common | Common Stock | 2024-02-28 | M | A | 117 | $63.55 | 13,053 | D | — | — | |
| 14 | Common | Common Stock | 2024-02-28 | S | D | 117 | $169.82 | 12,936 | D | — | — | (F8) The transaction was executed in multiple trades ranging from $169.790 to $170.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 15 | Common | Common Stock | 2024-02-28 | M | A | 90 | $63.55 | 13,026 | D | — | — | |
| 16 | Common | Common Stock | 2024-02-28 | S | D | 90 | $172.23 | 12,936 | D | — | — | |
| 17 | Common | Common Stock | 2024-02-28 | M | A | 5,000 | $0.00 | 17,936 | D | — | — | (F9) 10,000 performance stock units ("PSUs") were granted on February 28, 2023. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. All of the performance criteria were achieved and one-half of the PSUs granted, or 5,000 PSUs, vested on February 28, 2024. |
| 18 | Common | Common Stock | 2024-02-28 | S | D | 648 | $162.71 | 12,936 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $162.155 to $163.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 19 | Derivative | Stock Option (Right to Buy) | 2024-02-28 | M | D | 5,000 | $0.00 | 25,000 | D | $63.55 · — to 2032-02-28 | 5,000 Common Stock | (F12) 50,000 options were granted that vest in four equal annual installments with the first installment vesting on February 28, 2023. |
| 20 | Derivative | Performance Stock Units | 2024-02-28 | M | D | 5,000 | $0.00 | 5,000 | D | — · — to — | 5,000 Common Stock | (F13) Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2023, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. All of the performance criteria were achieved and one-half of the PSUs granted, or 5,000 PSUs, vested on February 28, 2024. (F14) The Performance Stock Units vest ratably over a two-year period with the first installment vesting on February 28, 2024. |
| 21 | Derivative | Performance Stock Units | 2024-02-29 | A | A | 15,000 | $0.00 | 15,000 | D | — · — to — | 15,000 Common Stock | (F16) The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the performance criteria set by the Company's Compensation Committee for this PSU award and full vesting. (F15) Each PSU represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. (F17) If any applicable portion of the performance criteria have been achieved, the PSU award shall vest in two equal annual installments (February 28, 2025 and February 28, 2026). (F18) If some or all of the performance criteria are not achieved, the applicable portion of the PSU award will be forfeited. |